Back

Stepwise intensification of guideline-directed medical therapy is associated with reduced major adverse kidney events in patients with HFpEF and diabetes

28 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: When heart, kidney, and metabolism collide: risk and missed opportunities in care Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yu Hoshika

Nippon Medical School Teaching Hospital, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
Persistent gender differences in the management of chronic kidney disease in patients with heart failure – follow-up of the InspeCKD study
Professor F. Mader (Erfurt-Altstadt, DE)
Abstract Slides Video
Presentation thumbnail
Association of cardiovascular-kidney-metabolic syndrome with cardiovascular mortality: a prospective cohort study in Madeira Island
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of chronic kidney disease and renal safety of contemporary therapies in patients with heart failure: a real-world analysis
Doctor P. Trapanese (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Bidirectional mendelian randomisation of kidney function and heart failure in african-ancestry populations
Doctor N. GAYE (Dakar, SN)
Abstract Slides Video
Presentation thumbnail
Chronic kidney disease in metabolic syndrome and heart failure: elevated risk, underutilized therapies, and missed opportunities for improved outcomes
Doctor D. Hochstein (Ramat Gan, IL)
Abstract Slides Video

Access the full session

Session thumbnail
When heart, kidney, and metabolism collide: risk and missed opportunities in care

The Event

Event poster

ESC Congress 2026

28 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Session
Treating heart failure with diabetes and renal disease
12 May 2024
thumbnail
Congress Presentation
Association between up-titration of guideline-directed medical therapy and clinical outcomes in patients with chronic heart failure with reduced ejection fraction
29 August 2026
thumbnail
Congress Presentation
Additive prognostic impact of chronic kidney disease and heart failure in patients with lower extremity artery disease
30 August 2026
thumbnail
Congress Presentation
Impact of a pre-discharge checklist on temporal trends in gdmt prescription and clinical events in patients with heart failure
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources